Back to "In the sleep restriction/ASA condition, ..."
Claim
Strong Support
mechanistic
Analysis v3

When low-dose aspirin is taken before sleep loss, it reduces inflammation; when taken after sleep loss begins, it does not.

47
Pro
0
Against

Mechanism

Synthesis from 1 study

How it works

Aspirin must be taken before sleep loss to block immune cells from producing inflammatory signals. Once sleep loss starts, the inflammatory process begins too quickly for aspirin to stop it if taken afterward.

Most probable mechanism

In Simple Terms

Taking aspirin before sleep loss stops immune cells from making inflammatory chemicals, which prevents the body from mounting a full inflammatory response when sleep is reduced.

Causal chain
1

Acetylsalicylic acid is absorbed and deacetylated to salicylate, which irreversibly acetylates cyclooxygenase-1 and cyclooxygenase-2 enzymes in monocytes

Verified by multiple studies
which leads to
2

Inhibition of cyclooxygenase enzymes reduces the conversion of arachidonic acid to prostaglandin H2, suppressing downstream pro-inflammatory eicosanoid production

Verified by multiple studies
which leads to
3

Reduced prostaglandin signaling dampens NF-κB activation and cytokine transcription in immune cells

Verified by multiple studies
which leads to
4

Lower interleukin-6 expression and C-reactive protein production occur as a direct result of suppressed inflammatory signaling

Verified by multiple studies

Evidence from Studies

Supporting (1)

47

Community contributions welcome

47

0174 Using Low-Dose Acetylsalicylic Acid to Target Inflammation in Response to Experimental Sleep Restriction in Humans

Randomized Controlled Trial
Human

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Sign up to see full verdict

Source Study

0174 Using Low-Dose Acetylsalicylic Acid to Target Inflammation in Response to Experimental Sleep Restriction in Humans

Score: 47
DOI: 10.1093/sleep/zsae067.0174

Similar Assertions

When people get insufficient sleep, taking low-dose aspirin lowers specific inflammatory markers—CRP, IL-6, and certain monocytes—but does not reduce other inflammatory signals or improve health outcomes.

47
0
90%

Taking low-dose aspirin does not change heart rate, blood pressure, or stroke volume when healthy adults are sleep-deprived in a controlled setting.

47
0
85%

Taking 81 mg of aspirin daily does not change baseline levels of inflammation in healthy adults who sleep normally, but it may reduce inflammation only when sleep is restricted.

47
0
73%

In healthy adults deprived of sleep for five nights, taking 81 mg of aspirin daily reduces the rise in certain white blood cells and lowers the CD4/CD8 T-cell ratio compared to taking no medication.

67
0
71%